Collage Medical Imaging
High-resolution Imaging and Diagnostics for Soft Tissue Cancers
Company Overview
Snapshot
Founded in January 2014 by Roni Zvuloni and Gavriel Iddan, Collage Medical Imaging operates with 1–10 employees. The company has secured funding across one round from Incubit Ventures. In January 2018, the company gained recognition as Israeli biotech veterans joined forces to revolutionize cancer diagnosis.
Business overview
Collage Medical Imaging is focused on developing advanced imaging and diagnostics technology specifically for soft tissues, such as the prostate, lung, and breast. The company's patented technology integrates high-quality miniature optical coherence tomography sensors with 3D localization sensors to produce ultra-high-resolution imaging, enabling real-time, precise identification and localization of cancerous tumors. This technology supports minimally invasive diagnostic and treatment strategies for various cancers, serving the healthcare industry within the medical devices and diagnostics sectors.
Strategic signal
In January 2018, Collage Medical Imaging was highlighted for its innovative approach to cancer diagnosis, with Israeli biotech veterans joining forces to advance its technology. This signals strong validation of the company's potential to revolutionize medical imaging and diagnostics, attracting experienced talent and reinforcing its strategic importance in the health tech sector.
Log in to access full profile ›Company Intelligence Q&A
- What is Collage Medical Imaging's primary focus?
- Collage Medical Imaging develops high-resolution imaging and diagnostics technology specifically for soft tissue cancers, including those affecting the prostate, lung, and breast.
- Who founded Collage Medical Imaging?
- Collage Medical Imaging was founded by Roni Zvuloni and Gavriel Iddan in January 2014.
- What is the core technology developed by Collage Medical Imaging?
- The company's patented technology combines miniature optical coherence tomography sensors with 3D localization sensors to generate ultra-high-resolution imaging of whole organs, aiming to pinpoint cancerous tumors with precision.
- Has Collage Medical Imaging conducted preclinical tests?
- Yes, Collage Medical Imaging has developed a prototype and conducted preclinical tests in collaboration with Harvard Medical School and Massachusetts General Hospital.
- Which investor participated in Collage Medical Imaging's funding round?
- Collage Medical Imaging received funding from Incubit Ventures in its seed round.